Effect of RECK in Posterior Spinal Fusion
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 1/2
- Started
- 1 Oct 2025
- Expected to end
- 1 Apr 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Ropivacaine, Epinephrine, Clonidine, and Ketorolac Injection Cocktail
- Placebo
- Record updated
- 31 July 2025
- Why it stopped
- Study was not feasible due to logistical and implementation challenges. No participants were enrolled and the study will not proceed further.
Who can take part
- Age
- 18 years to 88 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Age 18-88 years old
- Undergoing spinal fusion at 1-3 lumbar levels via a posterior approach
Who cannot take part
- Surgeries indicated for trauma, tumor, or infection
- Preoperative history of moderate to severe hepatic, renal, cardiac, or psychiatric illness
- Known hypersensitivity to any of the RECK components
- Revision surgeries
Where in United States
- University of Maryland Medical CenterBaltimore, United States
About the trial
What the trial wants to find out
"RECK" is a combination of local anesthesia medications, used for the purpose of pain control. RECK is an acronym which stands for Ropivacaine, Epinephrine, Clonidine, and Ketorolac. The purpose of this study is to investigate the effect of RECK local injectable anesthetic in the setting of posterior spinal fusion. Our specific aims are the following.
Read full original descriptionShow less
Primary aim: to investigate the effect of RECK local injectable anesthetic on postoperative VAS pain scores.
Secondary aims: to investigate of effect of RECK injection on postoperative opioid consumption and hospital length of stay.
Hypothesis: RECK injection will significantly decrease postoperative VAS pain score, opioid consumption, and hospital length of stay compared to placebo controls.
The 2 groups in the trial
- Intervention (RECK)Treatment being tested
The arm of patients who will be administered "RECK" local anesthesia cocktail: Ropivacaine 0.125g Clonidine 80 mcg Epinephrine 0.5 mg Ketorolac 30 mg In sterile water 73 mL (total volume of compound is 100 mL) Given through paraspinal muscle injection once intraoperatively.
Treatment: Ropivacaine, Epinephrine, Clonidine, and Ketorolac Injection Cocktail
- Control Group (Placebo)Placebo, for comparison
The arm of patients who will be administered a placebo injection: 100 mL Normal Saline Given through paraspinal muscle injection once intraoperatively.
Treatment: Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Local Injectable Ropivacaine, Epinephrine, Clonidine, and Ketorolac (RECK) Anesthetic Cocktail on Postoperative Pain in Posterior Spinal Fusion
- Record updated
- 31 July 2025